Tubulin inhibitor 41, identified by its CAS number 2770273-12-4, is a synthetic compound that functions as an inhibitor of tubulin polymerization, which is crucial for microtubule formation in cells. This compound is part of a broader class of agents that target the cytoskeletal structure, making it of interest in cancer research and treatment, as disrupting microtubule dynamics can lead to cell cycle arrest and apoptosis in rapidly dividing cancer cells. Typically, tubulin inhibitors exhibit characteristics such as high specificity for tubulin, potential cytotoxicity against tumor cells, and the ability to overcome resistance mechanisms in certain cancer types. The pharmacological profile of such compounds often includes considerations of solubility, bioavailability, and metabolic stability. Research into tubulin inhibitors like this one continues to explore their mechanisms of action, therapeutic efficacy, and potential side effects, contributing to the development of novel anticancer therapies.

Tubulin inhibitor 41

2770273-12-4: Tubulin inhibitor 41, identified by its CAS number 2770273-12-4, is a synthetic compound that functions as an inhibitor of tubulin polymerization, which is crucial for microtubule formation in cells. This compound is part of a broader class of agents that target the cytoskeletal structure, making it of interest in cancer research and treatment, as disrupting microtubule dynamics can lead to cell cycle arrest and apoptosis in rapidly dividing cancer cells. Typically, tubulin inhibitors exhibit characteristics such as high specificity for tubulin, potential cytotoxicity against tumor cells, and the ability to overcome resistance mechanisms in certain cancer types. The pharmacological profile of such compounds often includes considerations of solubility, bioavailability, and metabolic stability. Research into tubulin inhibitors like this one continues to explore their mechanisms of action, therapeutic efficacy, and potential side effects, contributing to the development of novel anticancer therapies.

Tubulin inhibitor 41 (Compd D19) is a promising lead compound for glioblastoma treatment, known for its ability to penetrate the blood-brain barrier (BBB). It functions as a tubulin inhibitor, inducing G2/M phase arrest, leading to cell apoptosis, and inhibiting the migration of U87 cells [1].

CAS 2770273-12-4

Tubulin inhibitor 41

Tubulin inhibitor 41

Ref: TM-T87573